Neuroprotective effects of curcumin-loaded nanophytosome on ketamine-induced schizophrenia-like behaviors and oxidative damage in male mice.
A. Hajizadeh Moghaddam, Khadijeh Maboudi, Bita Bavaghar, Seyed Reza Mokhtari Sangdehi, M. Zare
Neuroscience Letters September 15, 2021 DOI: 10.1016/j.neulet.2021.136249 (opens in new tab) via Semantic Scholar
Summary
AI-generated from the abstractCurcumin, an antioxidant natural herb, has poor bioavailability that limits its effects. A curcumin-loaded nanophytosome (CNP) formulation was developed and tested in a mouse model of schizophrenia induced by ketamine (KET). Mice received oral curcumin or CNP (20 mg/kg) for 30 days, with KET injections (30 mg/kg/day) from days 16 to 30. CNP showed greater neuroprotective effects than free curcumin, reducing depressive and anxiety-like behaviors, memory deficits, and oxidative stress markers in brain tissues. CNP may improve curcumin bioavailability and offer stronger protection against KET-induced behavioral and oxidative damage.
Study at a glance
| Characteristics | Preclinical study Peer reviewed |
|---|---|
| Population | Mice |
| Interventions | Curcumin Curcumin-loaded nanophytosome (CNP) |
| Dose | 20 mg/kg |
| Duration | 30 days |
| Keywords | Medicine Chemistry |
| Key finding | Curcumin-loaded nanophytosome (CNP) had greater neuroprotective effects than free curcumin against ketamine-induced behavioral deficits and oxidative stress in mice. |
Abstract
Curcumin as an antioxidant natural herb has shown numerous pharmacological effects. However, the poor bioavailability of curcumin is a significant pharmacological barrier for its antioxidant activities. The present study was conducted to develop curcumin-loaded nanophytosome (CNP) and explore their therapeutic potential in a ketamine (KET)-induced schizophrenia (SCZ) model. The mice in our experiment were treated orally with curcumin and CNP (20 mg/kg) for 30 consecutive days. In addition, the animals received intraperitoneal injection of KET (30 mg/kg/day) from the 16th to the 30th day. SCZ-like behaviors were evaluated employing forced swimming test (FST), open field test (OFT), and novel object recognition test (NORT), and oxidative stress markers in the brain were estimated. Our results revealed that CNP has a greater neuroprotective effect compared to free curcumin. CNP pretreatment significantly ameliorated KET-induced brain injury evidenced by a marked reduction in the depressive and anxiety-like behaviors, memory deficits, and oxidative stress markers in cortical and subcortical tissues. Therefore, CNP, as a suitable drug delivery system, may improve curcumin bioavailability and confer stronger neuroprotective effects against KET-induced behavioral deficits and oxidative damages.